SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-053553
Filing Date
2020-11-12
Accepted
2020-11-12 16:08:26
Documents
3
Period of Report
2020-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tptx-8k_20201112.htm 8-K 33039
2 EX-99.1 tptx-ex991_6.htm EX-99.1 229269
3 GRAPHIC gryzcj2bq5nf000001.jpg GRAPHIC 5311
  Complete submission text file 0001564590-20-053553.txt   271115
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38871 | Film No.: 201306675
SIC: 2834 Pharmaceutical Preparations